The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Novel screening approach for cancer cachexia using metagenomic gut microbiome profiling in patients with advanced non-small cell lung cancer.
 
Taiki Hakozaki
Speakers' Bureau - Chugai Pharma; Eisai; Ono Pharmaceutical
 
Eder Mendez Salazar
No Relationships to Disclose
 
Takayuki Kobayashi
No Relationships to Disclose
 
Shota Fukuoka
No Relationships to Disclose
 
Shohei Koyama
Consulting or Advisory Role - Kaken Pharmaceutical
Research Funding - Otsuka
 
Hiroyoshi Nishikawa
Stock and Other Ownership Interests - Cellian-Biclo; Sustainable Cell Therapeutics
Honoraria - Amgen; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; MSD K.K; Ono Pharmaceutical
Research Funding - Becton Dickinson; Bristol-Myers Squibb; Chugai Pharma; Debiopharm Group; Fujifilm; Hitachi; MiraBiologics Inc.; MSD K.K.; Oncolys BioPharma; Ono Pharmaceutical; Rakuten Medical; Sumitomo Dainippon Pharma; Taiho Pharmaceutical
 
Daisuke Motooka
No Relationships to Disclose
 
Shota Nakamura
No Relationships to Disclose
 
Yusuke Okuma
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca; Chugai Pharma; Eisai; Lilly; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - Abbvie (Inst); Chugai Pharma (Inst); MSD (Inst); Ono Pharmaceutical
 
Yukio Hosomi
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Eisai; Kyowa Kirin International; Lilly Japan; MSD; Nippon Kayaku; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
 
Haruko Takeyama
No Relationships to Disclose
 
Masahito Hosokawa
No Relationships to Disclose
 
Bertrand Routy
No Relationships to Disclose